您的购物车当前为空
别名 (S)-2-acetamido-3-(4-methylbenzoylthio)propanoic acid
SXC 2023 ((S)-2-acetamido-3-(4-methylbenzoylthio)propanoic acid) 是一种可治疗中枢神经疾病和神经认知障碍的N-乙酰-L-半胱氨酸的前药,可用于治疗谷氨酸能功能障碍和氧化应激起关键作用的精神疾病。


为众多的药物研发团队赋能,
让新药发现更简单!
SXC 2023 ((S)-2-acetamido-3-(4-methylbenzoylthio)propanoic acid) 是一种可治疗中枢神经疾病和神经认知障碍的N-乙酰-L-半胱氨酸的前药,可用于治疗谷氨酸能功能障碍和氧化应激起关键作用的精神疾病。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 109 | In Stock | |
| 5 mg | ¥ 219 | In Stock | |
| 10 mg | ¥ 313 | In Stock | |
| 25 mg | ¥ 495 | In Stock | |
| 50 mg | ¥ 793 | In Stock | |
| 100 mg | ¥ 1,360 | In Stock | |
| 200 mg | ¥ 1,980 | In Stock |
| 产品描述 | SXC 2023 ((S)-2-acetamido-3-(4-methylbenzoylthio)propanoic acid) is a therapeutic prodrug of N-acetyl-L-cysteine for the treatment of CNS disorders and neurocognitive disorders, and can be used to treat glutamatergic dysfunction and psychiatric disorders in which oxidative stress plays a key role. |
| 别名 | (S)-2-acetamido-3-(4-methylbenzoylthio)propanoic acid |
| 分子量 | 281.33 |
| 分子式 | C13H15NO4S |
| CAS No. | 1695562-36-7 |
| Smiles | C(SC[C@H](NC(C)=O)C(O)=O)(=O)C1=CC=C(C)C=C1 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 55 mg/mL (195.5 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容